The group's principle activities include researches, developing, manufacturing and marketing pharmaceutical drugs. The group's products include VACNO(R), HemoZyme(R), and DermoZyme(R). The group also provides caged nitric oxide (CNO) therapeutics based on biologic or non-biologic compounds. The group operates from United States.